C3 nephritic factor associated with C3 glomerulopathy in children (Q42246527)

19 October 2017

title

C3 nephritic factor associated with C3 glomerulopathy in children (English)

1 reference

Véronique Frémeaux-Bacchi

19 October 2017

4

Marie-Alice Macher

0 references

16

object named as

Véronique Frémeaux-Bacchi

1 reference

19 October 2017

3

Veronique Baudouin

0 references

author name string

Camille Nicolas

1

1 reference

19 October 2017

Vincent Vuiblet

2

1 reference

19 October 2017

Veronique Baudouin

3

1 reference

19 October 2017

Marie-Alice Macher

4

1 reference

19 October 2017

Isabele Vrillon

5

1 reference

19 October 2017

Nathalie Biebuyck-Gouge

6

1 reference

19 October 2017

Maud Dehennault

7

1 reference

19 October 2017

Sophie Gié

8

1 reference

19 October 2017

Denis Morin

9

1 reference

19 October 2017

Hubert Nivet

10

1 reference

19 October 2017

François Nobili

11

1 reference

19 October 2017

Tim Ulinski

12

1 reference

19 October 2017

Bruno Ranchin

13

1 reference

19 October 2017

Maria Chiarra Marinozzi

14

1 reference

19 October 2017

Stéphanie Ngo

15

1 reference

19 October 2017

Christine Pietrement

17

1 reference

19 October 2017

publication date

26 September 2013

1 reference

19 October 2017

1 reference

19 October 2017

volume

29

1 reference

19 October 2017

issue

1

1 reference

19 October 2017

page(s)

85-94

1 reference

C3 glomerulopathy: a new classification

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

New approaches to the treatment of dense deposit disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

C3 glomerulopathy: what's in a name?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Membranoproliferative glomerulonephritis type II (dense deposit disease): an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

21 January 2018

The Nephrotic Syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 Annual Report of the North American Pediatric Renal Transplant Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

C3 glomerulonephritis: clinicopathological findings, complement abnormalities, glomerular proteomic profile, treatment, and follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Alternative complement pathway assessment in patients with atypical HUS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Membranoproliferative glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Membranoproliferative glomerulonephritis--a new look at an old entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Severity of primary MPGN, rather than MPGN type, determines renal survival and post-transplantation recurrence risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Acute presentation and persistent glomerulonephritis following streptococcal infection in a patient with heterozygous complement factor H-related protein 5 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Causes of alternative pathway dysregulation in dense deposit disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Infections of People with Complement Deficiencies and Patients Who Have Undergone Splenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Clinical features and outcomes of 98 children and adults with dense deposit disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Childhood membranoproliferative glomerulonephritis type I: limited steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Treatment of mesangiocapillary glomerulonephritis in children with combined immunosuppression and anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Mycophenolate mofetil treatment for primary glomerular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Treatment of idiopathic membranoproliferative glomerulonephritis with mycophenolate mofetil and steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

21 January 2018

Dense deposit disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00467-013-2605-6

Immunosuppressive treatment of membranoproliferative glomerulonephritis

21 January 2018

1 reference

12 December 2020

Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation

1 reference

12 December 2020

Mesangiocapillary glomerulonephritis

1 reference

12 December 2020

Human complement factor H deficiency associated with hemolytic uremic syndrome.

1 reference

12 December 2020

Hypocomplementaemia of poststreptococcal acute glomerulonephritis is associated with C3 nephritic factor (C3NeF) IgG autoantibody activity

1 reference

12 December 2020

Management of membranoproliferative glomerulonephritis: evidence-based recommendations

1 reference

12 December 2020

Membranoproliferative glomerulonephritis: the Cincinnati experience--cumulative renal survival from 1957 to 1989

1 reference

12 December 2020

Mesangiocapillary glomerulonephritis type II (dense-deposit disease): clinical features of progressive disease

1 reference

12 December 2020

Pulse methylprednisolone therapy in children with membranoproliferative glomerulonephritis

1 reference

12 December 2020

Comparison of pulse and oral steroid in childhood membranoproliferative glomerulonephritis

1 reference

12 December 2020

Selective disappearance of C3NeF IgG autoantibody in the plasma of a patient with membranoproliferative glomerulonephritis following renal transplantation

1 reference

12 December 2020

10.1007/S00467-013-2605-6

Identifiers

DOI

1 reference

Dimensions Publication ID

19 October 2017

1041761797

0 references

1 reference